A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop bispecific antibody-based T-cell engager (TCE) therapies for ...

Ouro and Real Madrid Football Club have announced a strategic partnership agreement. The collaboration will develop and deliver co-branded financial solutions to fans in markets globally ...